Acute Heart Failure
Acute Heart Failure in the Emergency Department
Use of Biomarkers in the Emergency Department
Using Biomarker (BNP) Measurements
Other Useful Biomarkers for Diagnosis of HF
Biomarkers of AHF
Relationship Between Discharge BNP and Outcomes
PROTECT Secondary End Points: HF Hospitalization and Rehospitalization
Use of Biomarkers in AHF
Using Biomarkers Across the ARC of Heart Failure Hospitalization
Biomarkers Across the ARC of Heart Failure Hospitalizations
Using Biomarkers Across the ARC of Heart Failure Hospitalization
Decision Making in AHF
Decision Making in AHF
Efficacy and Limitations of Current AHF Therapies
Treatment of HF
Management of AHF
Vasodilators
Novel Therapies and Recent Clinical Data in the Treatment of
AHF
Therapy for AHF
Therapy for AHF
ATOMIC-AHF Omecamtiv MecarbilDyspnea Response
3 Buckets
Pre-RELAX-AHF: Rapid Dyspnea Improvement Through
24 hours (Likert Scale)
Serelaxin
RELAX-AHF
RELAX-AHF: Cardiovascular and All-Cause
Mortality
RELAX AHF: Biomarker Changes
Putting Readmissions Into Perspective
Readmissions
H2H Challenges: A Community Call-to-Action
RELAX-AHF
References
References (cont)
References (cont)
Abbreviations
Abbreviations (cont)